Navigation Links
Drug May Shrink Fibroids, Preserve Fertility
Date:7/1/2010

THURSDAY, July 1 (HealthDay News) -- Preliminary research suggests that a new drug treatment shrinks uterine fibroids and helps women with the non-cancerous tumors retain their fertility.

Uterine fibroids, which cause abdominal pain and heavy menstrual bleeding, are a leading cause of hysterectomy. They can also contribute to miscarriage.

"Both the fibroids and the surgical interventions commonly used to treat them can cause significant fertility problems," Dr. Alicia Armstrong, chief of gynecologic services at the U.S. National Institutes of Health's Program for Reproductive and Adult Endocrinology, said in a news release.

In two new studies, researchers tested a drug called ulipristal acetate (also known as ellaOne), which blocks ovulation and is used as a form of emergency contraception. It works by adjusting the body's reaction to the hormone progesterone.

In the studies, 57 women aged 25-50 with uterine fibroids were randomly assigned to receive treatment with the drug or a placebo. They took the pills once a day for three menstrual cycles.

The fibroids shrank in more of those women who took the drug instead of the placebo, and those who took higher doses had better results. Women who took the drug also had less bleeding than those who took the placebo.

The studies show that the drug "is an effective non-invasive treatment for fibroids that can help maintain fertility in women whose only option up to now was to have surgery," Dr. Lynnette Nieman, a principal investigator with the studies, said in the news release issued by the European Society of Human Reproduction and Embryology.

The studies are both in Phase II, the second in three phases of research required before the federal government will approve a drug for a specific use.

In an interview, Dr. Scott Chudnoff, a gynecologist and uterine fibroid specialist, said the research could lead to significant new treatments for women with fibroids. But some women might not respond the same way to the treatment, and the fibroids may return when women stop taking the drug, said Chudnoff, director of gynecology at Montefiore Medical Center in New York City.

Still, a new treatment would help doctors do a better job of personalizing their approach to individual patients, he said. The research, he added, is "definitely promising."

The study findings were to be presented Wednesday at the annual meeting of the European Society of Human Reproduction and Embryology in Rome.

More information

For more about uterine fibroids, visit the U.S. National Library of Medicine.

-- Randy Dotinga

SOURCES: Scott Chudnoff, M.D., assistant professor, department of obstetrics & gynecology and women's health, Albert Einstein College of Medicine, and director of gynecology, Montefiore Medical Center, New York City; European Society of Human Reproduction and Embryology, news release, June 30, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New lung cancer drug shows dramatic results for shrinking tumors
2. Virtual visits shrink the distance in stroke rehab
3. As girth grows, risk of sudden cardiac death shrinks
4. Drug for advanced kidney cancer shrinks tumors prior to surgery
5. Cognitive Skills May Shrink With Tamoxifen
6. GYN Oncologist Uses da Vinci Surgical Robot to Preserve Fertility
7. San Jose Parks Foundation Launches "ParkForce" Campaign to Protect and Preserve San Jose's Parks & Trails
8. Woodmeister Master Builders Announces Commitment to Preserve One Foot of Forest for Each Foot it Builds
9. Transplant drug preserves kidneys, avoids toxicity
10. Smell of old books offers clues to help preserve them
11. RESOLVE: The National Infertility Association Announces Partnership with Attain Fertility
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug May Shrink Fibroids, Preserve Fertility
(Date:2/22/2017)... ... February 22, 2017 , ... ... in recent years. The technology is so cutting edge, in fact, the U.S. ... for stem cell procedures. However, successful patient outcomes in certain clinical stem cell ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... its certification exam and eligibility requirements effective with the April 2017 testing period. ... 1995. , “The Care Manager Certified (CMC) exam is periodically re-calibrated to ...
(Date:2/22/2017)... Dallas, TX (PRWEB) , ... ... ... HCC Risk Adjustment solution leverages advanced data analytics to accurately understand each ... ensure proper reimbursement for a given population. This new solution helps transform ...
(Date:2/22/2017)... ... ... Doctors on Liens is continuing its steady expansion of medical specialties throughout ... North Valley Eye Medical Group in Mission Hills . Eye injuries and vision ... cases. These injuries have a major impact on the quality of life of ...
(Date:2/22/2017)... ... February 22, 2017 , ... Using the power of the ... simple online checklist. Over a period of just 24 months, thousands of individuals interested ... online checklist called T.A.D. , “The internet is not getting quieter. In fact it’s ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... 2017 IRIDEX Corporation (Nasdaq: IRIX ... for the fourth quarter and 2016 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
(Date:2/22/2017)... , Feb. 22, 2017 Summary ... infarction partnering deals and agreements entered into by ... full report: http://www.reportlinker.com/p03605670-summary/view-report.html Description The ... understanding and access to partnering deals and agreements ... - Trends in partnering deals ...
(Date:2/22/2017)... , Feb. 22, 2017 Merrimack Pharmaceuticals, Inc. ... will host its Fourth Quarter 2016 investor conference call and ... The call will cover an update on ... quarter and full year 2016 financial results. A press release ... be issued the morning of Wednesday, March 1. Investors and ...
Breaking Medicine Technology: